Search Results for "Mylan Atovaquone And Proguanil 250mg 100mg Tablet"

05:47 EDT 2nd July 2015 | BioPortfolio

Matching Channels

Selective monoamine oxidase type B MAOB inhibitors

The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...

Matching News

Mylan introduces Lamivudine Tablets, 100mg to treat hepatitis B virus

US-based pharmaceutical firm Mylan has introduced its Lamivudine Tablets, 100mg, which is the generic version of GlaxoSmithKline's Epivir-HBV.

Gilead and Mylan expand Sovaldi pact

Mylan Laboratories is expanding its hepatitis C licensing agreement with Gilead Sciences to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 an...

Chloroquine sulphate syrup has been discontinued

Chloroquine sulphate syrup (Nivaquine; Sanofi) has been discontinued and will no longer be marketed in the UK. The expiry date for the last batch supplied is March 2015. Other chloroquine phosphate sy...

Malaria: when an antimalarial drug is no longer fit for purpose

High fever, chills, cramps and severe anaemia are typical symptoms of malaria, even its mild form. According to World Health Organisation (WHO) estimates, around 660,000 people die from malaria every ...

UPDATE 4-Perrigo rejects raised Mylan bid; Teva recommits to Mylan buy

* Teva responds to Mylan rejection (Adds details from Teva letter to Mylan, updates shares)

Mylan Settles Patent Litigation With Pfizer On Viagra

CANONSBURG (dpa-AFX) - Mylan N.V. (MYL) announced that its subsidiaries Mylan Inc. and Mylan Pharmaceuticals Inc. reached a settlement and license agreement with Pfizer Inc. (PFE), Pfizer Limited ...

Mylan Rejects Buyout Bid By Teva; Remains Committed To Firm Offer For Perrigo

CANONSBURG (dpa-AFX) - Mylan N.V. (MYL) announced Monday that it has rejected the unsolicited expression of interest from Teva Pharmaceutical Industries Ltd. (TEVA) to acquire Mylan.The Mylan Boar...

Rejections All Around: Mylan to Teva, Perrigo to Mylan

Feeling pressured by the approval of a biosimilar Copaxone and by the increasing likelihood that Mylan will be out of its league once it acquires Perrigo, Teva Pharmaceuticals has finally jumped into ...

Matching PubMed Articles

Novel Mutation in Cytochrome B of Plasmodium falciparum in One of Two Atovaquone-Proguanil Treatment Failures in Travelers Returning From Same Site in Nigeria.

Atovaquone-proguanil (AP) is the most commonly used treatment for uncomplicated Plasmodium falciparum malaria in the United States. Apparent AP treatment failures were reported 7 months apart in 2 Ame...

Pharmacological rational of dry ripe fruit of Aegle marmelos L. as an anti-nociceptive agent in different painful conditions.

The aim of study is to investigate central and peripheral analgesic effects of methanolic extract of dry ripe fruit of Aegle marmelos Linn. Corea (Am. Cr) by two methods, tail flick test and acetic ac...

Estimation of Young's modulus of pharmaceutical tablet obtained by terahertz time-delay measurement.

In this paper, it is suggested that Young's modulus of pharmaceutical tablets with different porosity can be estimated from terahertz (THz) pulse time delay. We demonstrate such a possibility using a ...

A randomized, double-blind, controlled study: Ji-Tai tablet for the treatment of acute withdrawl syndrome of mild heroin dependence.

To investigate the efficacy and safety of Ji-Tai tablet and Ji-Tai tablet combined with buprenorphine in the treatment of patients with acute withdrawal syndrome of mild heroin dependence.

Gravitational demand on the neck musculature during tablet computer use.

Tablet computer use requires substantial head and neck flexion, which is a risk factor for neck pain. The goal of this study was to evaluate the biomechanics of the head-neck system during seated tabl...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement